IRIS
ARCOPINTO, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.462
NA - Nord America 1.642
AS - Asia 953
SA - Sud America 116
AF - Africa 70
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.248
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.594
RU - Federazione Russa 1.051
IT - Italia 715
SG - Singapore 472
HK - Hong Kong 219
DE - Germania 202
CN - Cina 181
NL - Olanda 132
UA - Ucraina 109
BR - Brasile 100
FI - Finlandia 79
FR - Francia 47
CI - Costa d'Avorio 44
CA - Canada 39
IN - India 36
IE - Irlanda 35
GB - Regno Unito 21
ZA - Sudafrica 14
AT - Austria 12
VN - Vietnam 12
CZ - Repubblica Ceca 11
SE - Svezia 11
BE - Belgio 10
KR - Corea 8
ID - Indonesia 7
AR - Argentina 6
CH - Svizzera 5
EC - Ecuador 4
EG - Egitto 4
AU - Australia 3
LT - Lituania 3
MA - Marocco 3
MT - Malta 3
SI - Slovenia 3
TR - Turchia 3
BG - Bulgaria 2
CO - Colombia 2
CU - Cuba 2
DO - Repubblica Dominicana 2
ES - Italia 2
GR - Grecia 2
IQ - Iraq 2
JO - Giordania 2
LU - Lussemburgo 2
MX - Messico 2
PA - Panama 2
TH - Thailandia 2
UG - Uganda 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
TN - Tunisia 1
Totale 5.248
Salva come PNG Salva come JPEG
Città #
Chandler 281
Moscow 271
Singapore 264
Hong Kong 216
Naples 127
Ashburn 120
Munich 108
Amsterdam 104
Santa Clara 102
Millbury 90
Beijing 53
Napoli 52
Des Moines 49
Helsinki 47
Milan 47
Princeton 37
Nanjing 33
Lawrence 30
Ottawa 29
Rome 29
Pune 23
Seattle 19
Boston 17
Salerno 15
Hefei 14
Wilmington 14
Los Angeles 13
Dong Ket 12
Düsseldorf 11
Jiaxing 11
Bologna 10
Frankfurt am Main 10
Olomouc 10
São Paulo 10
Falkenstein 9
Houston 9
Jacksonville 9
The Dalles 9
Fairfield 8
Redwood City 8
Seoul 8
Toronto 8
Woodbridge 8
Bandung 7
Boardman 7
Brussels 7
Guangzhou 7
Hebei 7
Nanchang 7
Vienna 7
Washington 7
Aosta 6
Catania 6
Changsha 6
Dearborn 6
Nuremberg 6
Perugia 6
Dallas 5
Ercolano 5
Gragnano 5
London 5
Nola 5
Palermo 5
Paris 5
Pontelandolfo 5
San Benedetto del Tronto 5
Shenyang 5
Ann Arbor 4
Avellino 4
Calvizzano 4
Delhi 4
Dublin 4
Kochi 4
Kronberg 4
Lamezia Terme 4
Lauterbourg 4
Tianjin 4
Andover 3
Augusta 3
Bari 3
Casavatore 3
Indiana 3
Jyväskylä 3
Lanzhou 3
Magenta 3
Melita 3
Messina 3
Monza 3
Mosnang 3
Norwalk 3
Padova 3
Pugliano 3
San Mateo 3
Sciacca 3
Serra D'aiello 3
Trieste 3
Adelaide 2
Amman 2
Ancona 2
Arapiraca 2
Totale 2.601
Salva come PNG Salva come JPEG
Nome #
Mini-Mental State Examination: new normative values on subjects in Southern Italy 312
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 198
Evidence-based directions for polypharmacy revision: The experience gained by the campania reference site in the framework of the eip-aha action group A1 and of the friendd pilot study 133
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 116
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 97
Growth hormone deficiency is associated with worse cardiac function, physical performance, and outcome in chronic heart failure: Insights from the T.O.S.CA. GHD study 95
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 95
Klinefelter syndrome, cardiovascular system, and thromboembolic disease: Review of literature and clinical perspectives 93
GH and the cardiovascular system: an update on a topic at heart 90
Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction 87
The Tosca Registry: An Ongoing, Observational, Multicenter Registry for Chronic Heart Failure 87
Bowel Angiodysplasia and Myocardial Infarction secondary to an ischaemic imbalance: A case report 85
Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction 84
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 83
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 77
Multiple hormone deficiencies in chronic heart failure 76
Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry 76
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 75
Primary prevention of cancer-related thrombosis: special focus on ambulatory patients 73
Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure 73
The T.O.S.CA. Project: research, education and care. 72
Human heart shifts from IGF-1 production to utilization with chronic heart failure 71
Growth Hormone as Biomarker in Heart Failure 69
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 68
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 67
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 66
Cardiovascular abnormalities in Klinefelter Syndrome 65
Hormone replacement therapy in heart failure 65
IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry 65
Biomarkers in Pulmonary Hypertension 65
Anti remodeling therapy: New strategies and future perspective in post-ischemic heart failure. Part II 65
The GH/IGF-1 axis in chronic heart failure. 64
Pregabalin-induced first degree atrioventricular block in a young patient treated for pain from extrapulmonary tuberculosis 64
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 64
Growth Hormone Therapy in Heart Failure 63
Gender-related differences in pulmonary arterial hypertension targeted drugs administration 62
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 62
Correction to: Human heart shifts from IGF-1 production to utilization with chronic heart failure (Endocrine, (2019), 65, 3, (714-716), 10.1007/s12020-019-01993-y) 62
Circulating cell-free DNA levels are associated with adverse outcomes in heart failure: testing liquid biopsy in heart failure 60
Risk factors for cancer-related venous thromboembolism in ambulatory patients. 58
Testosterone treatment in chronic heart failure. Review of literature and future perspectives 58
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 57
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry 57
Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia 56
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 56
Acute Heart Failure: Diagnostic-Therapeutic Pathways and Preventive Strategies-A Real-World Clinician's Guide 55
A giant pseudoaneurysm of the forearm as unusual complication of bacterial endocarditis. 55
Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study. 55
Combined effects of growth hormone and testosterone replacement treatment in heart failure 55
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 55
Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement: the complexity of the elderly 53
The impairment of the Growth Hormone/Insulin-like growth factor 1 (IGF-1) axis in heart failure: A possible target for future therapy 52
Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer 52
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 52
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice 50
Postoperative myocardial injury: Trying to square the circle 50
Exploring the Cardiotoxicity Spectrum of Anti-Cancer Treatments: Definition, Classification, and Diagnostic Pathways 49
Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry 48
Early Left Ventricular Diastolic Dysfunction in Females with Chronic Hyperprolactinemia: A Doppler Echocardiographic Study 48
Anti remodeling therapy: New strategies and future perspective in post-ischemic heart failure: Part I 48
Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential 47
Hormonal alterations in heart failure: anabolic impairment in chronic heart failure - diagnostic, prognostic and therapeutic issues 46
Cardiovascular Side Effects of Anthracyclines and HER2 Inhibitors among Patients with Breast Cancer: A Multidisciplinary Stepwise Approach for Prevention, Early Detection, and Treatment 45
An unusual case of dilated cardiomyopaty associated with partial hypopituitarism. 45
GH deficiency in mild-to-moderate chronic heart failure is associated to worse clinical status, cardiopulmonary performance, and LV remodeling 44
Hormonal Replacement Therapy in Heart Failure: Focus on Growth Hormone and Testosterone 43
Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre 43
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation 43
Implementing an ICT-Based Polypharmacy Management Program in Italy 42
Biomarkers and Imaging: Complementary or Subtractive? 42
Anabolic/catabolic imbalance in chronic heart failure 41
Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry 41
Beneficial Effects on Exercise Capacity Associated with a Combination of Lactoferrin, Lysozyme, Lactobacillus, Resveratrol, Vitamins, and Oligoelements in Patients with Post-COVID-19 Syndrome: A Single-Center Retrospective Study 40
What have we learned so far from the sex/gender issue in heart failure? An overview of current evidence 39
Cardiovascular abnormalities in the Low IGF-1 Syndrome: insights from the TOSCA project 38
Metabolic Syndrome in Heart Failure: Friend or Foe? 37
Detectable plasma levels of Interleukin-9 are associated with impaired exercise capacity and poor outcomes in Chronic Heart Failure and reduced ejection fraction 35
Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction 35
The impact of gender in cardiovascular medicine: Lessons from the gender/sex-issue in heart failure 31
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 30
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 30
Detectable plasma levels of interleukin-9 are associated with impaired exercise capacity and poor survival in chronic heart failure 29
Pulmonary arterial hypertension-related myopathy: An overview of current data and future perspectives 29
The dual relationship between polypharmacy and frailty in nursing home residents: polypharmacy as a cause or a consequence? 27
The role of curcumin in liver diseases 26
Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry 26
Hormonal alterations in heart failure: anabolic impairment in chronic heart failure - diagnostic, prognostic and therapeutic issues 21
Clinical and non-clinical determinants of pulmonary arterial hypertension development in severe autoimmune rheumatic diseases 20
Totale 5.478
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.253
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202059 0 0 0 0 0 0 0 0 0 0 44 15
2020/2021340 68 16 19 21 37 27 22 21 42 17 23 27
2021/2022494 9 6 14 4 14 16 9 19 42 57 137 167
2022/2023787 71 44 26 32 96 86 25 68 144 124 54 17
2023/2024692 27 81 108 60 42 78 29 92 10 21 83 61
2024/20252.639 144 118 20 58 76 174 346 217 233 333 920 0
Totale 5.478